Adaptimmune Therapeutics PLC ADR buy BiotechBee
Start price
22.07.24
/
50%
€1.11
Target price
30.09.26
€2.00
Performance (%)
-2.70%
Price
23.08.24
€1.08
Summary
This prediction is currently active. With a performance of -2.70%, the BUY prediction for Adaptimmune Therapeutics PLC ADR by BiotechBee is down slightly. This prediction currently runs until 30.09.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Adaptimmune Therapeutics PLC ADR | 10.769% | 10.769% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
According to BiotechBee what are the pros and cons of Adaptimmune Therapeutics PLC ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Adaptimmune Therapeutics PLC ADR diskutieren
Buy mit Kursziel 2,0
Stopped prediction by BiotechBee for Adaptimmune Therapeutics PLC ADR
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.10
07.07.24
07.07.24
€2.00
31.08.25
31.08.25
0.91%
22.07.24
22.07.24
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.12
29.04.24
29.04.24
€1.70
31.07.26
31.07.26
-1.79%
06.07.24
06.07.24
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€0.98
04.02.24
04.02.24
€1.50
31.10.25
31.10.25
14.29%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year